At Astria Therapeutics, our team is focused on bringing therapies with the potential to improve the quality of life to patients and families affected by Hereditary Angioedema (HAE) and rare allergic and immunological diseases.
Our name originates from the Greek word for star, and patients are guiding stars who guide us in the development of life-changing therapies. Learn more at www.astriatx.com
Our name originates from the Greek word for star, and patients are guiding stars who guide us in the development of life-changing therapies. Learn more at www.astriatx.com
Location: United States, Massachusetts, Boston
Employees: 11-50
Founded date: 2008
Investors 1
| Date | Name | Website |
| 02.11.2022 | Xontogeny | xontogeny.... |
Mentions in press and media 2
| Date | Title | Description |
| 21.02.2026 | Korsana Biosciences Launches With $175 Million To Advance Alzheimer’s Therapeutics | Korsana Biosciences, a biotechnology company focused on discovering and developing novel therapies to reduce the burden of neurodegenerative diseases, announced its emergence from stealth with $175 million in funding from a syndicate of hea... |
| 08.01.2022 | Astria Therapeutics : Corporate Presentation | Corporate Presentation January 2022 Forward Looking Statements This presentation and various remarks we make during this presentation contain forward-looking statements of Astria Therapeutics, Inc. ("Astria," the "Company,&qu... |